Conferences - Results from #9420

EAU 2011 - Androstenedione is the most efficient precursor of intraprostatic testosterone production in primary human prostate cancer tissue - Session Highlights May 11, 2011

EAU 2011 - Health-related quality of life after salvage high intensity focused ultrasound treatment (HIFU) for locally radiorecurrent prostate cancer - Session Highlights May 11, 2011

EAU 2011 - Prostate cancer associated up-regulation of AMACR, EZH2 and PSMA correlates with diminished expression of specific microRNAs - Session Highlights May 11, 2011

EAU 2011 - Serum levels of pro-inflammatory cytokines immediately increase two days after application of docetaxel in patients with castration-resistant prostate cancer and correlate with apoptosis and clinical response - Session Highlights May 11, 2011

EAU 2011 - Carbon footprint of laparoscopy in the United States - Session Highlights May 11, 2011

EAU 2011 - A meta-analysis comparing complication and positive surgical margin rates of 110,016 patients undergoing open retropubic, laparoscopic, and robotic-assisted radical prostatectomy - Session Highlights May 10, 2011

EAU 2011 - A multi-institutional study of 3794 patients undergoing robotic-assisted laparoscopic radical prostatectomy shows the learning curve is not as short as previously thought - Session Highlights May 10, 2011

EAU 2011 - Differences in biochemical recurrence rate after focal and extensive positive surgical margins following radical prostatectomy - Session Highlights May 10, 2011

EAU 2011 - Pathologic stage at prostatectomy over time: Has there been a trend toward intervention for localized disease in the robotic era? - Session Highlights May 10, 2011

EAU 2011 - Radical prostatectomy in men with continuous oral aspirin medication: Revisiting old paradigm? - Session Highlights May 10, 2011

EAU 2011 - Clinical benefit of cabazitaxel plus prednisone in the TROPIC trial in men with metastatic castration resistant prostate cancer (mCRPC) who progressed after docetaxel-based treatment - Session Highlights May 9, 2011

EAU 2011 - Clinical utility of PCA3 urine assay in Japanese men undergoing prostate biopsy - Session Highlights May 9, 2011

EAU 2011 - Deregulation of miR339 in prostate cancer and metastases - Session Highlights May 9, 2011

EAU 2011 - Long-term efficacy results from the phase 1-2 study of MDV3100 in pre- and post-docetaxel advanced prostate cancer - Session Highlights May 9, 2011

EAU 2011 - Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on saturation biopsy scheme - Session Highlights May 6, 2011

EAU 2011 - Evaluation of different molecular markers for the detection of minimal residual disease in lymph nodes of patients undergoing radical prostatectomy and extended pelvic lymph node dissection (PLND) - Session Highlights May 4, 2011

EAU 2011 - Interest of early confirmatory biopsies and centralized pathological review to select prostate cancer patients for active surveillance - Session Highlights May 4, 2011

EAU 2011 - Non-invasive diagnosis of prostate cancer from body fluids using a panel of tumor suppressor genes - Session Highlights May 4, 2011

EAU 2011 - The PCA3 score accurately predicts tumor volume and might help in selecting prostate cancer patients for active surveillance - Session Highlights May 4, 2011

EAU 2011 - Combining screening and chemoprevention of prostate cancer - Session Highlights May 3, 2011

Page 472 of 475

email news signup